Occurrence and molecular characterization of Klebsiella pneumoniae ST37 clinical isolates producing plasmid-mediated AmpC recovered over a 3-year period

Diagnostic Microbiology and Infectious Disease

Volumn 74, Issue 1, 2012, Pages 95-97

  Illiaquer, Marina ^a   Caroff, Nathalie ^b   Bémer, Pascale ^a   Aubin, Guillaume G ^a,b   Juvin, Marie Emmanuelle ^a   Lepelletier, Didier ^a,b   Reynaud, Alain ^a,b   Corvec, Stéphane ^a,b  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE NANTES   (France)

Author keywords

DHA 1; Klebsiella pneumoniae; Plasmidic cephalosporinase AmpC

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE AMPC; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CEPHALOSPORINASE; CIPROFLOXACIN; COTRIMOXAZOLE; ERTAPENEM; GENTAMICIN; IMIPENEM; NALIDIXIC ACID; NETILMICIN; NITROFURANTOIN; NORFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFAMETHOXAZOLE; TICARCILLIN; TOBRAMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BLOODSTREAM INFECTION; CATHETER INFECTION; CLINICAL ARTICLE; DEATH; FEMALE; HUMAN; INTENSIVE CARE; KLEBSIELLA PNEUMONIAE; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLASMID; PNEUMONIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; UNIVERSITY HOSPITAL;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CEFTAZIDIME; FEMALE; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; PLASMIDS;

EID: 84865289405     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2012.05.023     Document Type: Article

References (24)

1. Arpin C., Dubois V., Coulange L., André C., Fischer I., Noury P., et al. Extended-spectrum beta-lactamase-producing Enterobacteriaceae in community and private health care centers. Antimicrob Agents Chemother 2003, 47:3506-3514.
2. Barnaud G., Arlet G., Verdet C., Gaillot O., Lagrange P.H., Philippon A. Salmonella enteritidis: AmpC plasmid-mediated inducible beta-lactamase (DHA-1) with an ampR gene from Morganella morganii. Antimicrob Agents Chemother 1998, 42:2352-2358.
3. Bauernfeind A., Chong Y., Lee K. Plasmid-encoded AmpC beta-lactamases: how far have we gone 10 years after the discovery?. Yonsei Med J 1998, 39:520-525.
4. Bidet P., Burghoffer B., Gautier V., Brahimi N., Mariani-Kurkdjian P., El-Ghoneimi A., et al. In vivo transfer of plasmid-encoded ACC-1 AmpC from Klebsiella pneumoniae to Escherichia coli in an infant and selection of impermeability to imipenem in K. pneumoniae. Antimicrob Agents Chemother 2005, 49:3562-3565.
5. Briñas L., Lantero M., de Diego I., Alvarez M., Zarazaga M., Torres C. Mechanisms of resistance to expanded-spectrum cephalosporins in Escherichia coli isolates recovered in a Spanish hospital. J Antimicrob Chemother 2005, 56:1107-1110.
6. CA-SFM. Communiqué de l'antibiogramme de la Société Française de Microbiologie. January, 2010. Available from: http://www.sfm-microbiologie.org/UserFiles/file/CASFM/casfm_2010.pdf.
7. Corvec S., Crémet L., Caroff N., Dauvergne S., Le Floch R., Reynaud A., et al. Klebsiella pneumoniae clinical isolate coproducing SHV-2a, DHA-1, QnrB4, and AAC(6')-Ib-cr determinants in France. Diagn Microbiol Infect Dis 2009, 64:462-463.
8. Corvec S., Crémet L., Leprince C., Dauvergne S., Reynaud A., Lepelletier A., et al. Epidemiology of Escherichia coli clinical isolates producing AmpC plasmidic beta-lactamase during a 5-year period in a French teaching hospital. Diagn Microbiol Infect Dis 2010, 67:277-281.
9. Courpon-Claudinon A., Lefort A., Panhard X., Clermont O., Dornic Q., Fantin B., et al. Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features. Clin Microbiol Infect 2011, 17:557-565.
10. Diestra K., Miró E., Martí C., Navarro D., Cuquet J., Coll P., et al. Multiclonal epidemic of Klebsiella pneumoniae isolates producing DHA-1 in a Spanish hospital. Clin Microbiol Infect 2011, 17:1032-1036.
11. Driche Z, Salord H, Carricajo A, Perouse de Montclos M, Raulin O, Roure-Sobas C, et al. (2010) Prevalence and molecular characterization of plasmid-mediated AmpC B-lactamases among clinical isolates of Escherichia coli and Klebsiella spp. in Rhone-Alpes area, France. 20th ECCMID VIENNA 2010, 10th to 13th April 2010 Abstract P727.
12. Drieux L., Brossier F., Sougakoff W. Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide. Clin Microbiol Infect 2008, 14(Suppl. 1):90-103.
13. Jacoby G.A. AmpC beta-lactamases. Clin Microbiol Rev 2009, 22:161-182.
14. ACT-1 beta-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin phoe. Antimicrob Agents Chemother 2006, 50:3396-3406.
15. DHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 beta-lactamases. J Antimicrob Chemother 2007, 60:410-413.
16. Orsi G.B., García-Fernández A., Giordano A., Venditti C., Bencardino A., Gianfreda R., et al. Risk factors and clinical significance of ertapenem-resistant Klebsiella pneumoniae in hospitalised patients. J Hosp Infect 2011, 78:54-58.
17. Pai H., Kang C.-I., Byeon J.-H., Park W.B., Kim H.-B., Kim E.-C., et al. Epidemiology and clinical features of bloodstream infections caused by AmpC-type-beta-lactamase-producing Klebsiella pneumoniae. Antimicrob Agents Chemother 2004, 48:3720-3728.
18. Pérez-Pérez F.J., Hanson N.D. Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002, 40:2153-2162.
19. Philippon A., Arlet G., Jacoby G.A. Plasmid-determined AmpC-type beta-lactamases. Antimicrob Agents Chemother 2002, 46:1-11.
20. Pitout J.D.D., Laupland K.B. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008, 8:159-166.
21. Seo M.-R., Park Y.S., Pai H. Characteristics of plasmid-mediated quinolone resistance genes in extended-spectrum cephalosporin-resistant isolates of Klebsiella pneumoniae and Escherichia coli in Korea. Chemotherapy 2010, 56:46-53.
22. Verdet C., Benzerara Y., Gautier V., Adam O., Ould-Hocine Z., Arlet G. Emergence of DHA-1-producing Klebsiella spp. in the Parisian region: genetic organization of the ampC and ampR genes originating from Morganella morganii. Antimicrob Agents Chemother 2006, 50:607-617.
23. Woodford N., Turton J.F., Livermore D.M. Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol Rev 2011, 35:736-755.
24. Yan J.-J., Ko W.-C., Wu H.-M., Tsai S.-H., Chuang C.-L., Wu J.-J., et al. Complexity of Klebsiella pneumoniae isolates resistant to both cephamycins and extended-spectrum cephalosporins at a teaching hospital in Taiwan. J Clin Microbiol 2004, 42:5337-5340.